Wealth Enhancement Advisory Services, LLC Crispr Therapeutics Ag Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 94,100 shares of CRSP stock, worth $3.65 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
94,100
Previous 27,311
244.55%
Holding current value
$3.65 Million
Previous $1.07 Million
198.14%
% of portfolio
0.01%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CRSP
# of Institutions
487Shares Held
64.2MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$348 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$339 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$148 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$108 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.75MShares$107 Million0.07% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.03B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....